Bumetanide and Spirapril: Interaction Details

Brand names
Bumetanide
BumexEnbumyst
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Spirapril

We don't have a drug information page for Spirapril because it is no longer sold in the US: the FDA lists every approved version as discontinued. Have a question about Spirapril? Ask a pharmacist, free →

What Happens When You Take Bumetanide With Spirapril

What can happen when they are taken together (rated Moderate)

Postural (first dose)

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Marked postural hypotension has been described when an is started in a patient already receiving a . Hypotension after the first dose occurs most often in patients who are sodium depleted or hypovolemic as a result of use or dietary sodium restriction, and the drop in blood pressure is generally short-lived.89106

Pairing the two drug classes would be expected to enhance natriuresis. Paradoxically, however, ACE inhibitors can also blunt the diuretic and natriuretic response to diuretics and lower glomerular filtration, which may result in edema and fluid retention.53 No clinically significant interactions between these classes have been observed.

The Bumetanide and Spirapril Interaction, Explained

Taking bumetanide with spirapril can make your blood pressure drop too far, especially after the first dose of spirapril. Bumetanide is a water pill that lowers your body's fluid and salt, and spirapril relaxes your blood vessels. Together they can make you dizzy or lightheaded when you stand up, or even faint. This effect is usually short-lived and tends to happen soon after starting.

Over time, spirapril can sometimes make the water pill work less well, so swelling or weight gain may show up. Your care team can manage this by adjusting doses and timing and checking on you. Stand up slowly, and tell your pharmacist or doctor about dizziness or swelling.

interaction (no clinically significant PK interaction reported). vasodilation plus -induced sodium and volume depletion can cause marked first-dose postural . Onset is rapid; the response is usually transient. Evidence: probable.

  • Risk is highest in sodium-depleted or hypovolemic patients.
  • ACE may also reduce GFR and blunt and natriuretic response, with possible edema or fluid retention.
  • Management: if feasible, hold bumetanide 2 to 3 days before starting spirapril, then restart if BP or HF remains uncontrolled. Otherwise, start spirapril at a very low evening dose and monitor BP for 4 hours after the first dose.
  • Monitor BP, fluid status, and weight regularly for up to 2 weeks after dose changes.

See the 10 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Bumetanide and Spirapril Interact

The likely mechanism

Vasodilation and relative intra-vascular volume depletion

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Bumetanide and Spirapril Interaction

Your care team can plan around this, and the approach depends on your situation.

  • Possible approaches: your prescriber may pause the water pill for a few days before starting spirapril, or may start spirapril at a very low dose in the evening, with blood pressure checked for about four hours after the first dose.
  • Follow-up: your team may monitor your blood pressure, fluid status, and weight regularly for up to two weeks after doses change.
  • What you can do: keep taking your medicines as prescribed and do not stop or change either one on your own. Stand up slowly. Tell your pharmacist or prescriber about dizziness, fainting, swelling, or unusual weight gain.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Bumetanide or Spirapril need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there anything you'd monitor while I'm on both?

Literature Reports

3 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Influence of captopril on urinary excretion of furosemide in hypertensive subjects

    One study found that captopril did not change the or the effect of furosemide in hypertensive patients.1 More recent data, however, show that conventional doses of captopril dampen the natriuretic and diuretic effects of furosemide in patients with mild to moderate congestive heart failure.

    Sodium excretion rose by 623% during furosemide treatment, and this fell to 242% once captopril was added.2 Several authors have described weight gain, sodium retention, and peripheral edema in patients receiving diuretic therapy when were started.345

  2. Report 2 · Study title

    Interaction between furosemide and the converting enzyme inhibitor benazepril in healthy volunteers

    In a single-dose study, 12 healthy volunteers received oral benazepril (10 mg) and oral furosemide (40 mg), each alone and in combination. The of benazepril were not significantly affected.

    Urinary of total furosemide was 10% to 20% lower during combined administration. When each drug was given alone as a single dose, blood pressure and pulse were not significantly affected.

    With the combination, however, erect blood pressure decreased and pulse rate increased. The maximal effects occurred four hours after administration (122 to 104 mm Hg and 87 to 107 beats per minute, respectively). Most subjects who received the combination experienced dizziness, which occurred together with reductions in blood pressure.6

  3. Report 3 · Study title

    Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,255, captopril) in hypertensive patients

    captopril and furosemide therapy has been reported to potentiate the hypotensive effects of captopril. In one patient with high plasma renin activity who received 50 mg captopril and intravenous furosemide, blood pressure fell abruptly from 290/150 mm Hg to 135/60 mm Hg within 10 minutes.7

Bumetanide and Spirapril: Common Questions

How serious is the Bumetanide and Spirapril interaction?

It is rated moderate. Can be significant — usually manageable with monitoring.

How is the Bumetanide and Spirapril interaction managed?

Your care team can plan around this, and the approach depends on your situation. Possible approaches: your prescriber may pause the water pill for a few days before starting spirapril, or may start spirapril at a very low dose in the evening, with blood pressure checked for about four hours after the first dose. Follow-up: your team may monitor your blood pressure, fluid status, and weight regular… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "rapid". Effects can appear quickly, often within about 24 hours of combining the drugs.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Bumetanide and Spirapril Interaction

Ask in your own words about taking Bumetanide and Spirapril together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (10)

  1. Fujimura A, Shimokawa Y, & Ebihara A: Influence of captopril on urinary excretion of furosemide in hypertensive subjects. J Clin Pharmacol 1990; 30:538-542. PubMed
  2. McLay JS, McMurray JJ, Bridges AB, et al: Acute effects of captopril on the renal actions of furosemide in patients with chronic heart failure. Am Heart J 1993; 126:879-886. PubMed
  3. Cleland JGF, Gillen G, & Dargie HJ: The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure. Eur Heart J 1988; 9:132-141. DOI
  4. Odemuyiwa O, Gilmartin J, Kenny D, et al: Captopril and the diuretic requirements in moderate and severe chronic heart failure. Eur Heart J 1989; 10:586-590. PubMed
  5. Flapan AD, Davies E, Waugh C, et al: Acute administration of captopril lowers the natriuretic and diuretic response to a loop diuretic in patients with chronic cardiac failure. Eur Heart J 1991; 12:924-927. PubMed
  6. De Lepeleire I, Van Hecken A, Verbesselt R, et al: Interaction between furosemide and the converting enzyme inhibitor benazepril in healthy volunteers. Eur J Clin Pharmacol 1988; 34:465-468. PubMed
  7. Case DB, Atlas SA, Laragh JH, et al: Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,255, captopril) in hypertensive patients. Prog Cardiovasc Dis 1978; 21:195-206.
  8. Clementy J, Schwebig A, Mazaud C, et al: Comparative study of the efficacy and tolerance of Capozide and Moduretic administered in a single daily dose for the treatment of chronic moderate arterial hypertension. Postgrad Med J 1986; 62(suppl 1):132.
  9. Gluck Z, Beretta-Piccoli C, & Reubi FC: Long-term effects of captopril on renal function in hypertensive patients. Eur J Clin Pharmacol 1984; 26:315-323. PubMed
  10. Vlasses PH, Ferguson RK, & Chatterjee K: Captopril: clinical pharmacology and benefit-to-risk ratio in hypertension and congestive heart failure. Pharmacotherapy 1982; 2:1-17. DOI
Was this write-up helpful?

Other Serious Interactions of Bumetanide and Spirapril

Also serious with Bumetanide

Also serious with Spirapril

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Bumetanide

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring.
  • Moderate Can be significant — usually manageable with monitoring. This interaction.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs. This interaction.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.